Sign In
Buy MRNS
$0.550
+0 (+0%)
At Close: May 09, 2025
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud Lawsuit
11:00am, Tuesday, 09'th Jul 2024
Shareholders with losses of $100,000 or more are encouraged to contact the firm. LOS ANGELES , July 9, 2024 /PRNewswire/ -- The Law Offices of Frank R.
The Schall Law Firm Starts An Investigation Into Marinus Pharmaceuticals Inc And Calls On Affected Investors To Make Contact
11:00am, Tuesday, 09'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceut
NEW YORK, NY / ACCESSWIRE / July 8, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) - August 5, 2024 Deadline to Join - Contact Levi & Korsinsky
03:00pm, Monday, 08'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 8, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) - August 5, 2024 Deadline to Join - Contact Levi & Korsinsky
02:45pm, Monday, 08'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 8, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
The Schall Law Firm Begins A Probe Into Marinus Pharmaceuticals Inc And Encourages Impacted Investors To Get In Touch
02:30pm, Monday, 08'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceut
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Marinus Lawsuit - MRNS
12:30pm, Monday, 08'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 8, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Contact Levi & Korsinsky by August 5, 2024 Deadline to Join Class Action Against Marinus Pharmaceuticals, Inc.(MRNS)
12:30pm, Monday, 08'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 8, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Shareholders with losses of $100,000 or more are encouraged to contact the firm Shareholders with losses of $100,000 or more are encouraged to contact the firm
NEW YORK, NY / ACCESSWIRE / July 8, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marinus Pharmaceu
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) Shareholders
11:45am, Monday, 08'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 8, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) Shareholders
11:30am, Monday, 08'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 8, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
NEW YORK, NY / ACCESSWIRE / July 8, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
NEW YORK, NY / ACCESSWIRE / July 8, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
NEW YORK , July 8, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Marinus Pharmaceuticals, Inc. ("Marinus" or the "Company") (NASDAQ: MRNS) of a class action securities lawsuit. CLAS
